Founded in Monmouth Beach, NJ, Princeton Biomeditech Corporation focuses on advancing healthcare through rapid, point-of-care diagnostic products. Their core mission is to enhance patient care by providing reliable and efficient diagnostic tools. They offer a wide range of products including cardiac and tumor markers, veterinary diagnostics, and tests for fertility, infectious diseases, and drugs of abuse. Their market focus spans across healthcare providers, veterinary clinics, and research institutions.
Princeton Biomeditech has established itself as a leader in the diagnostics industry with notable achievements in product innovation and patent utilization. The company has garnered attention from key investors and industry leaders for its contributions to healthcare technology. Their impact is evident in the widespread adoption of their diagnostic tools, which have improved the speed and accuracy of medical testing globally.
Quick Facts
When was Princeton Biomeditech's last funding round?
Princeton Biomeditech's most recent funding round was for $9.9M (USD) in October 2021.
How much disclosed funding has Princeton Biomeditech raised?
As of Oct 22, 2021, Princeton Biomeditech has disclosed funding of $9.9M (USD).
